Prof. Dr. med. Hans-Ulrich Schildhaus

 
Staff Status
exunigoe
 

1-6 of 6
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2017 Journal Article
    ​ ​Interlaboratory-concordance of PD-L1 IHC for NSCLC.​
    Scheel, A. H.; Bänfer, G.; Baretton, G. B.; Dietel, M.; Diezko, R.; Henkel, T. & Heukamp, L. C. et al.​ (2017) 
    Journal of Clinical Oncology35(15_suppl) pp. e20508​-e20508​.​ DOI: https://doi.org/10.1200/JCO.2017.35.15_suppl.e20508 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Diagnostic PD-L1 immunohistochemistry in NSCLC: Results of the first German harmonization study.​
    Scheel, A. H.; Dietel, M.; Heukamp, L. C.; Jöhrens, K.; Kirchner, T.; Reu, S. & Ruschoff, J.  et al.​ (2016) 
    Journal of Clinical Oncology34(15_suppl) pp. 3028​-3028​.​ DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.3028 
    Details  DOI 
  • 2016 Journal Article
    ​ ​HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat​
    Angelika Ihle, M.; Merkelbach‐Bruse, S.; Hartmann, W.; Bauer, S. ; Ratner, N.; Sonobe, H. & Nishio, J. et al.​ (2016) 
    The Journal of Pathology2(2) pp. 59​-71​.​ DOI: https://doi.org/10.1002/cjp2.v2.2 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors​
    Ortiz-Cuaran, S.; Scheffler, M.; Plenker, D.; Dahmen, I.; Scheel, A. H.; Fernandez-Cuesta, L. & Meder, L. et al.​ (2016) 
    Clinical Cancer Research22(19) pp. 4837​-4847​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-15-1915 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients​
    Michels, S.; Scheel, A. H. J.; Scheffler, M.; Schultheis, A. M.; Gautschi, O. P.; Aebersold, F. & Diebold, J. et al.​ (2016) 
    Journal of Thoracic Oncology11(1) pp. 122​-+​.​ DOI: https://doi.org/10.1016/j.jtho.2015.09.016 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article
    ​ ​MET Amplification Status in Therapy-Naive Adeno- and Squamous Cell Carcinomas of the Lung​
    Schildhaus, H.-U. ; Schultheis, A. M.; Rüschoff, J. R. ; Binot, E.; Merkelbach-Bruse, S.; Fassunke, J. & Schulte, W. et al.​ (2015) 
    Clinical Cancer Research21(4) pp. 907​-915​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-14-0450 
    Details  DOI  PMID  PMC  WoS 

Publication List

Filter

Active filter:
Contributor:  Buettner, Reinhard

Type

Date issued

Author

Peer-Reviewed

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp44610
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.